A number of other brokerages have also recently commented on EVK. JPMorgan Chase & Co. set a €27.00 ($31.40) price objective on Evonik Industries and gave the stock a sell rating in a research note on Thursday, August 2nd. Sanford C. Bernstein set a €37.00 ($43.02) price objective on Evonik Industries and gave the stock a buy rating in a research note on Friday, September 14th. Commerzbank set a €39.00 ($45.35) price objective on Evonik Industries and gave the stock a buy rating in a research note on Thursday, August 2nd. Warburg Research set a €38.00 ($44.19) price objective on Evonik Industries and gave the stock a buy rating in a research note on Tuesday, September 18th. Finally, DZ Bank restated a neutral rating on shares of Evonik Industries in a research note on Thursday, July 5th. Five equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of Hold and a consensus price target of €35.10 ($40.81).
Shares of EVK opened at €27.89 ($32.43) on Tuesday. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: What does relative strength index mean?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.